CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 SAB Biotherapeutics, Inc. - SABS CFD

    0.91
    5.81%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.06
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* 0.86
    开仓* 0.9
    1 年变化* -52.38%
    日范围* 0.87 - 0.91
    52 周范围 0.37-2.19
    平均交易量（10 天） 58.20K
    平均交易量（3 个月) 28.52M
    市值 46.19M
    市盈率 -100.00K
    流通股 50.40M
    收入 12.68M
    EPS -0.60
    股息（收益率 %） N/A
    贝塔 -100.00K
    下一个财报发布日期 Aug 8, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 2, 2023 0.86 0.00 0.00% 0.86 0.88 0.86
    Jun 1, 2023 0.87 0.00 0.00% 0.87 0.89 0.85
    May 31, 2023 0.85 0.02 2.41% 0.83 0.88 0.83
    May 30, 2023 0.87 0.05 6.10% 0.82 0.88 0.82
    May 26, 2023 0.84 0.01 1.20% 0.83 0.86 0.82
    May 25, 2023 0.82 -0.04 -4.65% 0.86 0.86 0.82
    May 24, 2023 0.87 0.04 4.82% 0.83 0.87 0.83
    May 23, 2023 0.84 -0.02 -2.33% 0.86 0.87 0.81
    May 22, 2023 0.87 0.06 7.41% 0.81 0.90 0.80
    May 19, 2023 0.79 -0.03 -3.66% 0.82 0.83 0.79
    May 18, 2023 0.83 0.03 3.75% 0.80 0.85 0.80
    May 17, 2023 0.82 0.05 6.49% 0.77 0.83 0.77
    May 16, 2023 0.75 -0.08 -9.64% 0.83 0.83 0.73
    May 15, 2023 0.85 -0.01 -1.16% 0.86 0.90 0.84
    May 12, 2023 0.90 -0.03 -3.23% 0.93 0.95 0.85
    May 11, 2023 0.90 -0.02 -2.17% 0.92 0.94 0.89
    May 10, 2023 0.93 0.05 5.68% 0.88 0.93 0.88
    May 9, 2023 0.89 -0.01 -1.11% 0.90 0.95 0.86
    May 8, 2023 0.94 0.10 11.90% 0.84 0.97 0.82
    May 5, 2023 0.84 0.03 3.70% 0.81 0.86 0.79

    SAB Biotherapeutics, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Wednesday, June 14, 2023

    时间（协调世界时） (UTC)

    18:30

    国家/地区

    US

    事件

    SAB Biotherapeutics Inc R&D Day
    SAB Biotherapeutics Inc R&D Day

    Forecast

    -

    Previous

    -
    Thursday, July 6, 2023

    时间（协调世界时） (UTC)

    14:00

    国家/地区

    US

    事件

    SAB Biotherapeutics Inc Annual Shareholders Meeting
    SAB Biotherapeutics Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Tuesday, August 8, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q2 2023 SAB Biotherapeutics Inc Earnings Release
    Q2 2023 SAB Biotherapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    时间（协调世界时） (UTC)

    13:30

    国家/地区

    US

    事件

    Q3 2023 SAB Biotherapeutics Inc Earnings Release
    Q3 2023 SAB Biotherapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020
    总收入 23.9042 60.8761 55.2378
    收入 23.9042 60.8761 55.2378
    总营业费用 52.8218 73.6037 34.681
    销售/一般/行政费用，总计 16.3833 17.0857 6.7723
    研究与开发 36.0325 57.1836 27.9087
    异常费用（收入） 0 -0.6656 0
    营业收入 -28.9176 -12.7276 20.5568
    利息收入（费用），非经营净值 10.1687 -4.42241 -0.44302
    其他，净值 0.03375 0.00549 0.004
    税前净收入 -18.7152 -17.1445 20.1178
    税后净收入 -18.7408 -17.1445 20.1178
    未计算非常项目前的净收益 -18.7408 -17.1445 20.1178
    净收入 -18.7408 -17.1445 20.1178
    普通股股东可获收益 (不含非经常性项目) -18.7408 -17.1445 20.1178
    普通股股东可获收益 (含非經常性項目) -18.7408 -17.1445 20.1178
    摊薄净收入 -18.7408 -17.1445 20.1178
    摊薄后加权平均股 43.525 42.9551 27.0115
    扣除特别项目的每股摊薄盈利 -0.43058 -0.39913 0.74479
    Dividends per Share - Common Stock Primary Issue 0
    每股正常摊薄盈利 -0.43058 -0.41462 0.74479
    Depreciation / Amortization 0.284
    利息费用（收入) - 净运营 0.122
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0.5811 2.16087 3.58971 18.1536 11.8031
    总营业费用 7.98311 10.0209 11.397 31.4039 18.5104
    Other Operating Expenses, Total -0.092
    营业收入 -7.40201 -7.86001 -7.80731 -13.2503 -6.70734
    利息收入（费用），非经营净值 0.04818 -0.02118 0.72972 9.46015 7.78549
    其他，净值 0.03223 0.00153 0
    税前净收入 -7.35382 -7.84897 -7.07607 -3.79014 1.07814
    税后净收入 -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    未计算非常项目前的净收益 -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    净收入 -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    普通股股东可获收益 (不含非经常性项目) -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    普通股股东可获收益 (含非經常性項目) -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    摊薄净收入 -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    摊薄后加权平均股 50.397 44.9728 43.0309 43.0366 43.1133
    扣除特别项目的每股摊薄盈利 -0.14592 -0.1751 -0.16444 -0.08807 0.02287
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.14592 -0.1751 -0.16444 -0.08807 0.02287
    收入 0.5811 2.16087 3.58971 18.1536 11.8031
    销售/一般/行政费用，总计 3.44739 2.88277 4.04405 9.45647 5.18607
    研究与开发 4.44172 7.04411 7.25698 21.7314 13.2113
    异常费用（收入） 0 0 0 0
    Depreciation / Amortization 0.025 0.186 0.025 0.073 0.041
    利息费用（收入) - 净运营 0.069 0.071 0.143 0.072
    • 年度
    • 每季度
    2022 2021 2020
    流动资产总额 22.0975 50.192 34.455
    现金和短期投资 15.0469 33.2067 12.6104
    现金等价物 15.0469 33.2067 12.6104
    应收账款总额，净额 5.55658 8.01071 20.5695
    Accounts Receivable - Trade, Net 5.55658 8.01071 20.5695
    Prepaid Expenses 1.49398 2.63622 1.27513
    Other Current Assets, Total 0 6.33831 0
    Total Assets 50.9049 81.1409 56.5379
    Property/Plant/Equipment, Total - Net 28.3398 30.949 22.0829
    Property/Plant/Equipment, Total - Gross 34.6183 34.169 23.8501
    Accumulated Depreciation, Total -6.27852 -3.22002 -1.76719
    Total Current Liabilities 14.9933 26.4553 11.0617
    Accounts Payable 3.67912 4.45853 7.38236
    Accrued Expenses 10.3588 13.382 2.82914
    Notes Payable/Short Term Debt 0 0 0
    Current Port. of LT Debt/Capital Leases 0.90545 1.95777 0.73345
    Other Current Liabilities, Total 0.05 6.65692 0.11678
    Total Liabilities 19.8468 42.591 17.5301
    Total Long Term Debt 4.17129 3.76243 4.09559
    Long Term Debt 0.54164 0 0.17204
    Capital Lease Obligations 3.62964 3.76243 3.92355
    Other Liabilities, Total 0.68216 12.3733 2.37278
    Total Equity 31.0581 38.5499 39.0078
    Common Stock 0.00509 0.00435 0.0026
    Additional Paid-In Capital 84.4441 67.6745 50.9897
    Retained Earnings (Accumulated Deficit) -47.8698 -29.129 -11.9844
    Total Liabilities & Shareholders’ Equity 50.9049 81.1409 56.5379
    Total Common Shares Outstanding 50.3943 43.4873 25.9734
    Other Long Term Assets, Total 0.46769 0
    Treasury Stock - Common -5.52125 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 15.032 22.0975 22.1821 27.7505 36.1697
    现金和短期投资 13.0601 15.0469 8.33219 16.6165 22.4084
    Cash
    Prepaid Expenses 1.20878 1.49398 0.90787 1.52138 1.97491
    Total Assets 42.672 50.9049 52.5075 59.1549 67.4725
    Long Term Investments
    Other Long Term Assets, Total 0.434 0.46769 0.50139 0.53508
    Total Current Liabilities 13.6657 14.9933 17.1012 16.1372 18.2559
    Accrued Expenses 8.65427 10.3588 11.3686 10.9954 12.9613
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 18.2695 19.8468 21.8841 22.0336 26.2142
    Total Long Term Debt 4.13777 4.17129 3.66254 3.69483 3.72894
    Other Liabilities, Total 0.466 0.68216 1.12029 2.2016 4.22939
    Total Equity 24.4025 31.0581 30.6234 37.1213 41.2583
    Common Stock 0.00509 0.00509 0.00436 0.00436 0.00435
    Additional Paid-In Capital 85.1423 84.4441 76.1355 75.5572 74.9183
    Retained Earnings (Accumulated Deficit) -55.2236 -47.8698 -39.9952 -32.9191 -28.1431
    Total Liabilities & Shareholders’ Equity 42.672 50.9049 52.5075 59.1549 67.4725
    Total Common Shares Outstanding 50.3978 50.3943 43.0309 43.0309 42.9551
    现金等价物 13.0601 15.0469 8.33219 16.6165 22.4084
    应收账款总额，净额 0.76312 5.55658 12.942 9.61267 11.7864
    Accounts Receivable - Trade, Net 0.76312 5.55658 12.942 9.61267 11.7864
    Other Current Assets, Total 0 0 0 0
    Property/Plant/Equipment, Total - Net 27.206 28.3398 29.824 30.8693 31.3027
    Accounts Payable 1.44496 3.67912 5.48428 4.94358 4.98139
    Current Port. of LT Debt/Capital Leases 0.57729 0.90545 0.1659 0.16578 0.17091
    Other Current Liabilities, Total 2.9892 0.05 0.0825 0.0325 0.14228
    Long Term Debt 0.54164 0.54164
    Capital Lease Obligations 3.59613 3.62964 3.66254 3.69483 3.72894
    Property/Plant/Equipment, Total - Gross 34.383 34.6183 35.2037 35.3823 35.0665
    Accumulated Depreciation, Total -7.17698 -6.27852 -5.37971 -4.51296 -3.76377
    Treasury Stock - Common -5.52125 -5.52125 -5.52125 -5.52125 -5.52125
    • 年度
    • 每季度
    2022 2021 2020
    净收入/起跑线 -18.7408 -17.1445 20.1178
    经营活动产生的现金 -23.4595 1.98687 10.0048
    经营活动产生的现金 3.16943 1.48861 0.38314
    非现金物品 -7.65056 5.95965 1.45821
    营运资金的变化 -0.23758 11.6831 -11.9543
    投资活动产生的现金 -2.09002 -10.9437 -12.7227
    资本支出 -2.16641 -10.9437 -12.7317
    其他投资现金流量项目，总计 0.07639 0.009
    融资活动产生的现金 1.05141 35.8914 8.98232
    股票的发行（报废），净额 2.23652 34.347 10.5618
    债务的发行（退还），净额 -1.18511 1.54444 -1.5795
    现金净变化 -24.4981 26.9346 6.26441
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -7.35382 -18.7408 -10.8662 -3.79013 0.98586
    Cash From Operating Activities -1.60572 -23.4595 -23.6762 -15.5026 -9.53773
    Non-Cash Items 0.63844 -7.65056 -8.23501 -8.05345 -6.92504
    Changes in Working Capital 4.21121 -0.23758 -6.84564 -5.04444 -4.32706
    Cash From Investing Activities -0.0213 -2.09002 -1.97227 -1.89377 -1.28093
    Other Investing Cash Flow Items, Total 0 0.07639 0.07639 0.07639 0.07639
    Cash From Financing Activities -0.35979 1.05141 -5.56433 -5.53216 -6.31795
    Financing Cash Flow Items
    Issuance (Retirement) of Stock, Net 0.00189 2.23652 -5.44427 -5.44428 -5.51342
    Issuance (Retirement) of Debt, Net -0.36168 -1.18511 -0.12005 -0.08788 -0.80453
    Net Change in Cash -1.98681 -24.4981 -31.2128 -22.9285 -17.1366
    Cash From Operating Activities 0.89845 3.16943 2.27062 1.38543 0.63624
    Capital Expenditures -0.0213 -2.16641 -2.04866 -1.97016 -1.35732
    Deferred Taxes 0 0.09228
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Sullivan (Eddie Joe) Individual Investor 10.3786 5230564 0 2023-05-12 LOW
    Hamilton (Christine E) Individual Investor 9.9074 4993090 0 2023-05-12 LOW
    Hamilton (Edward D.) Individual Investor 6.1675 3108270 0 2023-05-12
    First Premier Bank Bank and Trust 1.6023 807535 0 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.3921 701584 0 2023-03-31 LOW
    Kropotova (Alexandra) Individual Investor 1.1409 575000 275000 2023-03-14
    Big Cypress Holdings, L.L.C. Corporation 1.0868 547698 0 2023-05-12
    Veritable, L.P. Investment Advisor/Hedge Fund 1.005 506513 0 2023-03-31 LOW
    Spragens (Jeffrey G.) Individual Investor 0.7837 394989 299002 2023-05-12 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5963 300529 0 2023-03-31 LOW
    First Manhattan Co. LLC Investment Advisor 0.5512 277777 277777 2023-03-31 LOW
    Reich (Samuel J.) Individual Investor 0.4127 208001 0 2023-05-12
    Warberg Asset Management LLC Hedge Fund 0.3525 177659 -192711 2023-03-31 HIGH
    IFAM Capital Investment Advisor 0.2972 149774 0 2023-03-31 LOW
    Meteora Capital LLC Hedge Fund 0.2669 134524 0 2023-03-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2102 105959 1860 2023-03-31 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.1667 84000 0 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1612 81241 0 2023-03-31 LOW
    Hightower Advisors, LLC Investment Advisor 0.1458 73470 -2500 2023-03-31 LOW
    Link (David Charles) Individual Investor 0.1377 69410 0 2023-05-12 HIGH

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    SAB Biotherapeutics, Inc. Company profile

    关于 SAB Biotherapeutics Inc.

    SAB Biotherapeutics公司，前身为Big Cypress Acquisition Corp.，是一家处于临床阶段的生物制药公司。 该公司提供名为DiversitAb平台的治疗引擎，以生产一类新的有针对性的多克隆抗体，而不需要人类供体。 其DiversitAb平台能够生产多克隆抗体疗法，以应对现代健康挑战的出现、变异和多样性，包括COVID-19、季节性流感、1型糖尿病和癌症。 其候选产品包括SAB-176、SAB-185、SAB-142和SAB-181。 公司正在开发新的免疫疗法，利用人类自身的免疫反应，跨越治疗类别，包括传染病免疫系统疾病和免疫肿瘤学。

    Industry: Biotechnology & Medical Research (NEC)

    2100 East 54Th Street North
    Suite 202
    SIOUX FALLS
    SOUTH DAKOTA 57104
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.51 Price
    -7.500% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00384

    Oil - Crude

    71.97 Price
    -0.030% 1D Chg, %
    多头隔夜费 -0.0149%
    空头隔夜费 -0.0070%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    BTC/USD

    25,777.35 Price
    -5.540% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    Gold

    1,961.75 Price
    +0.680% 1D Chg, %
    多头隔夜费 -0.0184%
    空头隔夜费 0.0102%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易